4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-25-005704
Chief Medical Officer acquired 850,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Arbet-Engels Christophe Chief Medical Officer | 2025-02-12 | Grant or award | +850,000 | 864,207 | D |
Loading xslF345X05/wk-form4_1739567336.xml…